These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 21219841

  • 1. [Prevention of herpes zoster by vaccination].
    Kofoed K, Rønholt F, Gerstoft J, Sand C.
    Ugeskr Laeger; 2011 Jan 10; 173(2):110-4. PubMed ID: 21219841
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM, Brisson M, Levin MJ.
    Vaccine; 2007 Nov 28; 25(49):8326-37. PubMed ID: 17980938
    [Abstract] [Full Text] [Related]

  • 3. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G.
    Expert Rev Vaccines; 2010 Mar 28; 9(3 Suppl):31-5. PubMed ID: 20192716
    [Abstract] [Full Text] [Related]

  • 4. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF.
    J Am Acad Dermatol; 2007 Dec 28; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [Abstract] [Full Text] [Related]

  • 5. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
    Wutzler P.
    Dtsch Med Wochenschr; 2009 Apr 28; 134 Suppl 2():S90-4. PubMed ID: 19353479
    [Abstract] [Full Text] [Related]

  • 6. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
    Lecrenier N, Beukelaers P, Colindres R, Curran D, De Kesel C, De Saegher JP, Didierlaurent AM, Ledent EY, Mols JF, Mrkvan T, Normand-Bayle M, Oostvogels L, Da Silva FT, Vassilev V, Vinals C, Brecx A.
    Expert Rev Vaccines; 2018 Jul 28; 17(7):619-634. PubMed ID: 30028651
    [Abstract] [Full Text] [Related]

  • 7. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
    Marino MG, Bagnato B, Torella I, Franco E.
    Ig Sanita Pubbl; 2009 Jul 28; 65(3):299-311. PubMed ID: 19629155
    [Abstract] [Full Text] [Related]

  • 8. Herpes zoster virus vaccine.
    Woolery WA.
    Geriatrics; 2008 Oct 28; 63(10):6-9. PubMed ID: 18828650
    [Abstract] [Full Text] [Related]

  • 9. [Pain in herpes zoster: Prevention and treatment].
    Calvo-Mosquera G, González-Cal A, Calvo-Rodríguez D, Primucci CY, Plamenov-Dipchikov P.
    Semergen; 2017 Oct 28; 43(4):318-327. PubMed ID: 27053513
    [Abstract] [Full Text] [Related]

  • 10. The impact of varicella zoster virus: chronic pain.
    Opstelten W, McElhaney J, Weinberger B, Oaklander AL, Johnson RW.
    J Clin Virol; 2010 May 28; 48 Suppl 1():S8-13. PubMed ID: 20510265
    [Abstract] [Full Text] [Related]

  • 11. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ, Schmader K.
    Herpes; 2007 Sep 28; 14 Suppl 2():45-7. PubMed ID: 17939896
    [Abstract] [Full Text] [Related]

  • 12. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
    Franco E, Gabutti G, Bonanni P, Conversano M, Stefano Valente ME, Ferro A, Icardi G, Antonio Volpi ML, Maggi S, Rossi A, Scotti S, Vitale F, Greco D, Italian Universities and Epidemiology.
    Ig Sanita Pubbl; 2014 Sep 28; 70(1):111-27. PubMed ID: 24770367
    [Abstract] [Full Text] [Related]

  • 13. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K, Weinberg JM.
    J Drugs Dermatol; 2006 Oct 28; 5(9):863-6. PubMed ID: 17039651
    [Abstract] [Full Text] [Related]

  • 14. Prevention and management of trigeminal herpes zoster and postherpetic neuralgia.
    Closmann JJ, Fielding CG, Pogrel MA.
    Gen Dent; 2008 Oct 28; 56(6):563-6; quiz 567-8, 591-2. PubMed ID: 18810918
    [Abstract] [Full Text] [Related]

  • 15. Herpes zoster vaccine. Poorly effective in those who need it most.
    Prescrire Int; 2012 Dec 28; 21(133):291. PubMed ID: 23373094
    [Abstract] [Full Text] [Related]

  • 16. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine.
    Hurley LP, Harpaz R, Daley MF, Crane LA, Beaty BL, Barrow J, Babbel C, Marin M, Steiner JF, Davidson A, Dickinson LM, Kempe A.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S216-23. PubMed ID: 18419400
    [Abstract] [Full Text] [Related]

  • 17. [Zoster vaccine].
    Wutzler P.
    Klin Monbl Augenheilkd; 2010 May 01; 227(5):384-7. PubMed ID: 20490991
    [Abstract] [Full Text] [Related]

  • 18. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
    MMW Fortschr Med; 2006 May 01; Spec no.1():14-5. PubMed ID: 16872127
    [No Abstract] [Full Text] [Related]

  • 19. Vaccination to prevent herpes zoster in older adults.
    Gnann JW.
    J Pain; 2008 Jan 01; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [Abstract] [Full Text] [Related]

  • 20. Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
    Johnson RW.
    Aging Clin Exp Res; 2009 Jun 01; 21(3):236-43. PubMed ID: 19571648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.